Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Blood. 2013 Mar 21;121(12):2244-52. doi: 10.1182/blood-2012-11-468900. Epub 2013 Jan 16.
Modulation of T-cell responses by HIV occurs via distinct mechanisms, 1 of which involves inactivation of T cells already at the stage of virus-cell fusion. Hydrophobic portions of the gp41 protein of the viral envelope that contributes to membrane fusion may modulate T-cell responsiveness. Here we found a highly conserved sequence (termed "ISLAD") that is associated with the membranotropic gp41 loop region. We showed that ISLAD has the ability to bind the T-cell membrane and to interact with the T-cell receptor (TCR) complex. Furthermore, ISLAD inhibited T-cell proliferation and interferon-γ secretion that resulted from TCR engagement through antigen-presenting cells. Moreover, administering ISLAD (10 µg per mouse) to an experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis reduced the severity of the disease. This was related to the inhibition of pathogenic T-cell proliferation and to reduced pro-inflammatory cytokine secretion in the lymph nodes of ISLAD-treated EAE mice. The data suggest that T-cell inactivation by HIV during membrane fusion may lie in part in this conserved sequence associated with the gp41 loop region.
HIV 通过不同机制调节 T 细胞反应,其中之一涉及到在病毒-细胞融合阶段使 T 细胞失活。病毒包膜的 gp41 蛋白的疏水部分有助于膜融合,可能调节 T 细胞的反应性。在这里,我们发现了一个高度保守的序列(称为“ISLAD”),它与膜转导 gp41 环区相关。我们表明,ISLAD 具有结合 T 细胞膜并与 T 细胞受体(TCR)复合物相互作用的能力。此外,通过抗原呈递细胞,ISLAD 抑制 TCR 结合引起的 T 细胞增殖和干扰素-γ分泌。此外,在多发性硬化症的实验性自身免疫性脑脊髓炎(EAE)模型中给予 ISLAD(每只小鼠 10µg)可降低疾病的严重程度。这与致病性 T 细胞增殖的抑制和淋巴结中促炎细胞因子分泌的减少有关。这些数据表明,HIV 在膜融合过程中使 T 细胞失活可能部分归因于与 gp41 环区相关的这个保守序列。